Results 1 to 5 of about 5 (5)

"Don't Think Twice, It's All Right": Using Additional Data to Reduce Uncertainty Regarding Oncologic Drugs Provided Through Managed Access Agreements in England. [PDF]

Pharmacoecon Open, 2023
Kang J, Cairns J.
europepmc   +1 more source

Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma. [PDF]

Pharmacoecon Open, 2019
Bullement A, Nathan P, Nathan P, Willis A, Amin A, Lilley C, Stapelkamp C, Hatswell A, Pescott C, Bharmal M.   +9 more
europepmc   +1 more source

Screening and genomic evaluation of keratinolytic protease producing Chryseobacterium sp. from tannery waste and its potential application in dehairing of goat skin. [PDF]

J Genet Eng Biotechnol
Akter T, Sarkar MH, Sarker SS, Tarannum N, Naser SR, Chowdhury SF, Parveen S.   +6 more
europepmc   +1 more source

Comparison of a Scheimpflug imaging with other screening indices in diagnosing keratoconus and keratoconus suspect. [PDF]

Sci Rep
Huo Y, Xie R, Chen X, Li S, Zou H, Liu Y, Wang Y.   +6 more
europepmc   +1 more source

Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer. [PDF]

Pharmacoeconomics
Hatswell AJ, Chaudhary MA, Monnickendam G, Moreno-Koehler A, Frampton K, Shaw JW, Penrod JR, Lawrance R.   +7 more
europepmc   +1 more source